Organ-on-a-chip (OOC) technology aims to more accurately reproduce human physiology in vitro, addressing the limitations of current approaches. This field is advancing rapidly. Image Credit: CN Bio ...

For those considering adding Organ-on-a-chip (OOC) technology into the workflow, it may be unclear where to start. Firstly, using a commercially available solution, such as CN Bio's PhysioMimix ®, ...

The current drug discovery process is inefficient, with a significant number of drugs halting clinical trials, pending more investigational work to understand causality, or failing due to unforeseen ...

CAMBRIDGE, England--(BUSINESS WIRE)--CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has received the ‘Most ...

Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10M and $5.5M, respectively Investment will expand product development and scaling of the organization to meet ...

Organs-on-chips (OoCs) represent a revolutionary advancement in the study of human physiology and disease, offering an in vitro microphysiological environment that mimics the functions of human organs ...

Researchers at Tampere University have developed a groundbreaking cell culture platform that enables the formation of two distinct but interconnected vascular networks. Their breakthrough holds ...

CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, today announced the establishment of a strategic partnership with ...

Organs-on-chips (OoCs) represent a revolutionary advancement in the study of human physiology and disease, offering an in vitro microphysiological environment that mimics the functions of human organs ...